Clovis Oncology Inc (NASDAQ:CLVS)
| 3.15 Delayed Data As of Nov 30 |  +0.06 / +1.94%Today’s Change | 3.02 Today|||52-Week Range 11.10 | -34.37% Year-to-Date |
Latest CLVS News | Press Releases
No recent news for Clovis Oncology Inc.
Today’s Trading
| Previous close | 3.09 |
| Today’s open | 3.08 |
| Day’s range | 3.03 - 3.18 |
| Volume | 320,461 |
| Average volume (3 months) | 3,032,733 |
| Market cap | $419.2M |
Data as of 4:04pm ET, 11/30/2021
Growth & Valuation
| Earnings growth (last year) | +41.08% |
| Earnings growth (this year) | +47.40% |
| Earnings growth (next 5 years) | +86.83% |
| Revenue growth (last year) | +15.05% |
| P/E ratio | NM |
| Price/Sales | 2.46 |
| Price/Book | -- |
Competitors
| ---- | ||
| MIRMMirum Pharmaceutical... | +1.27 | +9.73% |
| MRNSMarinus Pharmaceutic... | +0.10 | +0.86% |
| IPHAInnate Pharma SA | -0.01 | -0.20% |
Data as of 4:00pm ET, 11/30/2021
Financials
| Next reporting date | February 23, 2022 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $164.5M |
| Annual profit (last year) | -$369.2M |
| Net profit margin | -224.41% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
